Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic analysis of systemic autoimmunity.

Carola G Vinuesa1, Matthew C Cook

  • 1John Curtin School of Medical Research and Medical School, Australian National University, Canberra, Australia.

Novartis Foundation Symposium
|May 31, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: TLR7 in systemic lupus erythematosus: genetics and emerging therapies.

Nature reviews. Rheumatology·2026
Same author

TLR7 in systemic lupus erythematosus: genetics and emerging therapies.

Nature reviews. Rheumatology·2026
Same author

Diversify and conquer: Antibody feedback in the germinal center.

Immunity·2026
Same author

2'-O-Methyl-guanosine RNA fragments antagonize TLR7 and TLR8 to limit autoimmunity.

Nature immunology·2026
Same author

Call for transparency regarding diagnostic certainty in Abusive Head Trauma.

Forensic science international. Synergy·2026
Same author

CD39 is an antibody-secreting B-cell marker that modulates germinal center and antibody responses during infection.

Frontiers in immunology·2025

Identifying rare genetic variants with strong effects in complex diseases like lupus (SLE) can reveal novel disease pathways and therapeutic targets. This study found that specific mutations in mice can fully replicate lupus phenotypes, highlighting the importance of rare alleles.

Area of Science:

  • Genetics
  • Immunology
  • Autoimmune Diseases

Background:

  • Complex diseases, such as systemic lupus erythematosus (SLE), often show high concordance in monozygotic twins, yet causative genetic alleles remain difficult to identify.
  • Explanations include multiple common variants with weak effects or heterogeneous allelic spectra with strong effects from rare variants.
  • Systemic lupus erythematosus (SLE) is characterized by a complex phenotype, autoantibody production, and evidence suggesting multiple molecular defects.

Purpose of the Study:

  • To investigate the role of rare genetic variants in complex autoimmune diseases.
  • To identify novel genes and pathogenic pathways involved in lupus (SLE) development.
  • To explore the potential of rare variants as therapeutic targets.

Main Methods:

Related Experiment Videos

  • Analysis of ENU-mutagenized mouse models.
  • Phenotypic characterization of mutant mice, including autoantibody production and immune cell function.
  • Genetic mapping to identify causative mutations, exemplified by the sanroque strain.

Main Results:

  • Homozygous mutations in ENU-mutagenized mice frequently induced anti-nuclear antibodies (ANAs) and recapitulated a full lupus phenotype.
  • The sanroque strain exhibited high-affinity dsDNA autoantibodies and impaired self-reactive T cell censorship.
  • Mapping the mutation in sanroque mice identified a novel gene, Roquin, and a previously unknown pathogenic pathway for SLE.

Conclusions:

  • Rare genetic variants with strong effects can be instrumental in uncovering disease mechanisms for complex conditions like SLE.
  • The identification of Roquin and its associated pathway provides new insights into SLE pathogenesis.
  • This approach holds promise for identifying interacting molecular partners and effective therapeutic targets for autoimmune diseases.